Literature DB >> 1312466

Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.

C Brakebusch1, Y Nophar, O Kemper, H Engelmann, D Wallach.   

Abstract

The mechanistic relationship between the signalling for the TNF effects by the human p55 TNF receptor (hu-p55-TNF-R) and the formation of a soluble form of the receptor, which is inhibitory to these effects, was explored by examining the function of C-terminally truncated mutants of the receptor, expressed in rodent cells. The 'wild-type' receptor signalled for a cytocidal effect when cross-linked with specific antibodies and exhibited spontaneous shedding. Shedding of the receptor was not affected by TNF but was markedly enhanced by 4 beta-phorbol-12-myristate-13-acetate (PMA). Receptor mutants with 53%, 83% and 96% C-terminal deletions could not signal for the cytocidal effect. Furthermore, they were found to associate with the endogenous rodent receptors, interfering with their signalling. Yet even the deletion of 96% of the intracellular domain did not abolish shedding of the receptor in response to PMA. These findings suggest that signalling and shedding of the p55 TNF-R are mechanistically distinct.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312466      PMCID: PMC556535          DOI: 10.1002/j.1460-2075.1992.tb05133.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Binding of human TNF-alpha to high-affinity cell surface receptors: effect of IFN.

Authors:  S Israel; T Hahn; H Holtmann; D Wallach
Journal:  Immunol Lett       Date:  1986-04       Impact factor: 3.685

2.  A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

Authors:  T Kohno; M T Brewer; S L Baker; P E Schwartz; M W King; K K Hale; C H Squires; R C Thompson; J L Vannice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.

Authors:  M Lantz; U Gullberg; E Nilsson; I Olsson
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

5.  Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.

Authors:  R A Heller; K Song; M A Onasch; W H Fischer; D Chang; G M Ringold
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Isolation and characterization of a tumor necrosis factor binding protein from urine.

Authors:  I Olsson; M Lantz; E Nilsson; C Peetre; H Thysell; A Grubb; G Adolf
Journal:  Eur J Haematol       Date:  1989-03       Impact factor: 2.997

7.  Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.

Authors:  F C Kull; S Jacobs; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms.

Authors:  J R Downing; M F Roussel; C J Sherr
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

9.  Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators.

Authors:  R Unglaub; B Maxeiner; B Thoma; K Pfizenmaier; P Scheurich
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

10.  Shedding of tumor necrosis factor receptors by activated human neutrophils.

Authors:  F Porteu; C Nathan
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  28 in total

Review 1.  The role of anti-cytokine therapy in the failing heart.

Authors:  A Deswal; A Misra; B Bozkurt
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

2.  Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice.

Authors:  D Kreder; O Krut; S Adam-Klages; K Wiegmann; G Scherer; T Plitz; J M Jensen; E Proksch; J Steinmann; K Pfeffer; M Krönke
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  Involvement of FAN in TNF-induced apoptosis.

Authors:  B Ségui; O Cuvillier; S Adam-Klages; V Garcia; S Malagarie-Cazenave; S Lévêque; S Caspar-Bauguil; J Coudert; R Salvayre; M Krönke; T Levade
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 4.  Cytokine receptors: structure and signal transduction.

Authors:  B M Foxwell; K Barrett; M Feldmann
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

5.  The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure.

Authors:  M Leist; F Gantner; G Künstle; I Bohlinger; G Tiegs; H Bluethmann; A Wendel
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

Review 6.  Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms.

Authors:  C Trautwein; K Böker; M P Manns
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

7.  Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition.

Authors:  M Schreiber; L Sedger; G McFadden
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1.

Authors:  Yaping Jiang; Min Yu; Xuena Hu; Lu Han; Kun Yang; Hongping Ba; Zunyue Zhang; Bingjiao Yin; Xiang-Ping Yang; Zhuoya Li; Jing Wang
Journal:  Cell Death Differ       Date:  2017-02-10       Impact factor: 15.828

9.  Signal transduction by tumor necrosis factor mediated by JNK protein kinases.

Authors:  H K Sluss; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein.

Authors:  F Dastot; M L Sobrier; P Duquesnoy; B Duriez; M Goossens; S Amselem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.